US Health Partners, LLC

est. 2Y upside i

Healthcare

Rank

#2809

Sector

Healthcare Services

Est. Liquidity

~5Y

Data Quality

Data: Low

Due to critical missing financial data (revenue, valuation, funding, growth), a meaningful equity upside analysis is impossible.

Last updated: July 3, 2026

Bull (20%)0%

Cannot compute upside due to missing financials. If the company executes well, long-term potential exists but no quantified scenario.

Base (55%)0%

Insufficient data to project. Stale valuation (Dec 2022) and no current revenue or growth rate provided.

Bear (25%)-100%

High incumbent threat from hospital systems and Optum could erode market position. Without financial data, worst-case is total loss.

Est. time to liquidity~5.0 years

Preference Stack Risk

low

Funding Intensity

Total funding amount is unknown, so cannot assess preference overhang. Likely moderate given PE backing but data missing.

Dilution Risk

high

No information on future fundraising needs; given high capital intensity and no revenue data, dilution risk is uncertain but potentially significant.

Secondary Liquidity

none

No secondary market activity or implied valuation reported.

Other — 1 role

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on US Health Partners, LLC's data — designed to show you've done your homework.

1
“What is the company's current annual revenue and growth rate?”
2
“What was the valuation in the last round, and has there been any secondary trading since?”
3
“What is the total preferred liquidation preference and how does it affect common stock?”

Our model estimates 0% upside. What do you think?

Anonymous. Do not share material non-public information.

Comments are reviewed before they appear publicly.

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.